Damora Therapeutics, Inc. (DMRA)
NASDAQ: DMRA · Real-Time Price · USD
25.63
-3.07 (-10.68%)
Mar 10, 2026, 2:53 PM EDT - Market open

Damora Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
7.6114.1821.4732.7962.56163.58
Short-Term Investments
--11.6927.4437.63-
Cash & Short-Term Investments
7.6114.1833.1560.22100.19163.58
Cash Growth
-61.35%-57.24%-44.95%-39.89%-38.75%1348.40%
Other Current Assets
2.182.663.623.699.915.71
Total Current Assets
9.7916.8436.7763.91110.1169.3
Net Property, Plant & Equipment
0.110.130.331.171.040.89
Long-Term Investments
---5.839.05-
Other Long-Term Assets
0.840.161.132.282.031.42
Total Assets
10.7417.1338.2373.19122.22171.6
Accounts Payable
0.520.381.73.351.532.85
Accrued Expenses
2.10.824.137.763.012.72
Total Current Liabilities
2.621.25.8311.114.545.57
Long-Term Leases
0.060.060.070.330.450.54
Other Long-Term Liabilities
0.050.04----
Total Long-Term Liabilities
0.110.10.070.330.450.54
Total Liabilities
2.731.35.911.444.996.11
Additional Paid-in Capital
292.47291.9288.04279.73273.66269.18
Accumulated Other Comprehensive Income
0.820.10.38-0.24-0.320.67
Retained Earnings
-286.63-277.52-256.09-217.74-156.11-104.36
Total Common Shareholders' Equity
8.0115.8332.3361.75117.22165.49
Minority Interest
1.341.36----
Shareholders' Equity
9.3517.1932.3361.75117.22165.49
Total Liabilities & Equity
10.7417.1338.2373.19122.22171.6
Total Debt
0.060.060.070.330.450.54
Net Cash (Debt)
7.5514.1133.0959.999.74163.04
Net Cash Growth
-46.51%-57.34%-44.76%-39.95%-38.82%1371.09%
Net Cash Per Share
5.7112.2031.1358.9398.71891.38
Book Value
8.0115.8332.3361.75117.22165.49
Book Value Per Share
6.0613.6830.4260.76116.01904.77
Tangible Book Value
8.0115.8332.3361.75117.22165.49
Tangible Book Value Per Share
6.0613.6830.4260.76116.01904.77
Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.